CTSE — Cathepsin E
Overview
flowchart TD
CTSE["CTSE"] -->|"regulates"| MLL["MLL"]
CTSE["CTSE"] -->|"regulates"| TFE3["TFE3"]
Menin["Menin"] -->|"regulates"| CTSE["CTSE"]
CTSB["CTSB"] -->|"regulates"| CTSE["CTSE"]
style CTSE fill:#4fc3f7,stroke:#333,color:#000
CTSE (Cathepsin E) is a gene located on chromosome 1q31.3 that encodes an aspartic protease belonging to the pepsin superfamily. Unlike other cathepsins that are widely expressed, Cathepsin E exhibits a more restricted tissue distribution, with high expression in immune cells (particularly macrophages and dendritic cells), gastric mucosa, and lower expression in various brain regions including the hippocampus and olfactory bulb. The gene is catalogued as NCBI Gene ID [1519](https://www.ncbi.nlm.nih.gov/gene/1519) and OMIM [131100](https://omim.org/entry/131100) [@hook2002].
...CTSE — Cathepsin E
Overview
Mermaid diagram (expand to render)
CTSE (Cathepsin E) is a gene located on chromosome 1q31.3 that encodes an aspartic protease belonging to the pepsin superfamily. Unlike other cathepsins that are widely expressed, Cathepsin E exhibits a more restricted tissue distribution, with high expression in immune cells (particularly macrophages and dendritic cells), gastric mucosa, and lower expression in various brain regions including the hippocampus and olfactory bulb. The gene is catalogued as NCBI Gene ID [1519](https://www.ncbi.nlm.nih.gov/gene/1519) and OMIM [131100](https://omim.org/entry/131100) [@hook2002].
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Cathepsin E</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>CTSE</td></tr>
<tr><td><strong>Full Name</strong></td><td>Cathepsin E</td></tr>
<tr><td><strong>Chromosome</strong></td><td>1q31.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[1519](https://www.ncbi.nlm.nih.gov/gene/1519)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[131100](https://omim.org/entry/131100)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000105638</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P10111](https://www.uniprot.org/uniprot/P10111)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Inflammatory Disorders</td></tr>
</table>
</div>
Molecular Structure and Function
Protein Structure
Cathepsin E is a member of the aspartic protease family characterized by two conserved Asp-Thr-Gly motifs in the active site. The enzyme is synthesized as a preproenzyme (426 amino acids) and undergoes proteolytic processing to form the mature enzyme. Unlike cathepsin D, another lysosomal aspartic protease, cathepsin E is predominantly localized in endosomal compartments and the trans-Golgi network rather than in lysosomes. This subcellular distribution suggests distinct functional roles in antigen processing and intracellular protein degradation [@ctsestructure2021].
Catalytic Mechanism
As an aspartic protease, cathepsin E utilizes two aspartate residues in the active site to catalyze peptide bond hydrolysis. The enzyme exhibits optimal activity at acidic pH (pH 3.5-5.0) but retains partial activity at neutral pH, which is relevant to its function in extracellular compartments and certain disease states. Substrate specificity studies have identified preferences for hydrophobic and aromatic residues at the P1 and P1' positions, with particular affinity for sequences found in amyloid precursor protein (APP) processing sites [@ctsestructure2021].
Tissue Distribution and Expression
Cathepsin E expression is highly cell-type specific:
- Immune cells: Highest expression in macrophages, monocytes, and dendritic cells
- Gastrointestinal tract: Abundant in gastric mucosa and intestinal epithelium
- Brain: Low to moderate expression in neurons, microglia, and astrocytes
- Hippocampus (CA1-CA3 regions)
- Olfactory bulb
- Cerebral cortex
- Substantia nigra
Expression data is available from the [Allen Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=CTSE) [@zhang2005] and shows region-specific patterns that may be relevant to neurodegenerative disease susceptibility.
Role in Alzheimer's Disease
Cathepsin E has been implicated in both the production and degradation of amyloid-beta (Aβ) peptides, the central pathogenic molecules in Alzheimer's disease. The enzyme can:
Direct Aβ degradation: Cathepsin E can cleave Aβ peptides, particularly Aβ1-40 and Aβ1-42, potentially reducing extracellular amyloid plaque burden. This antiamyloidogenic function contrasts with some findings for cathepsin B [@muellersteiner2006].
APP processing: Cathepsin E can process amyloid precursor protein (APP) through non-amyloidogenic pathways, potentially reducing Aβ generation. The enzyme interacts with APP in endosomal compartments where Aβ production primarily occurs.
Microglial regulation: A 2022 study demonstrated that microglial cathepsin E plays a critical role in regulating neuroinflammation and amyloid-beta production in AD. Knockdown of cathepsin E in microglia reduced Aβ generation while decreasing pro-inflammatory cytokine release, suggesting a complex dual role in disease pathogenesis [@microglialctse2022].Neuroinflammation
Cathepsin E is increasingly recognized as a key regulator of neuroinflammation in AD:
- Microglial activation: Cathepsin E in microglia contributes to the inflammatory cascade by regulating cytokine production and inflammasome activation
- Astrocyte function: Recent research (2023) shows astrocyte-derived cathepsin E influences neuroinflammation through paracrine signaling to neurons and other glial cells [@astrocytecathepsin2023]
- T cell infiltration: The enzyme participates in antigen processing for MHC class II presentation, potentially affecting adaptive immune responses in the brain
Relationship with Other Cathepsins
Cathepsin E shares overlapping substrate specificity with cathepsin D, another aspartic protease implicated in AD. Both enzymes can degrade Aβ and process APP, but they exhibit distinct expression patterns and subcellular localization. Studies in cathepsin D-deficient mice suggest compensatory upregulation of cathepsin E, indicating potential functional redundancy [@cathepsind2020].
Role in Parkinson's Disease
In Parkinson's disease, cathepsin E expression is altered in dopaminergic neurons of the substantia nigra. The enzyme may contribute to:
- Alpha-synuclein degradation and aggregation
- Lysosomal dysfunction characteristic of PD
- Neuronal apoptosis through caspase-dependent pathways
Therapeutic Implications
Cathepsin E as a Therapeutic Target
Cathepsin E represents a potential therapeutic target for AD due to its roles in Aβ metabolism and neuroinflammation. However, the dual nature of its functions—protective Aβ degradation versus pro-inflammatory signaling—creates complexity for therapeutic modulation. Selective inhibitors must consider these opposing effects [@cathepsininhibitors2023].
Biomarker Potential
Elevated cathepsin E levels in cerebrospinal fluid (CSF) and plasma have been detected in AD patients, suggesting potential utility as a biomarker for disease diagnosis and progression. The enzyme's association with microglial activation makes it particularly relevant for tracking neuroinflammation.
Expression in Neurodegenerative Disease Context
Cellular Localization in Brain
- Neurons: Cytoplasmic and endosomal localization
- Microglia: Lysosomal and endosomal compartments
- Astrocytes: Secreted and intracellular forms
- Oligodendrocytes: Lower expression
Regional Vulnerability
The selective vulnerability of specific brain regions in AD correlates with cathepsin E expression patterns. The hippocampus, which shows early pathology in AD, exhibits moderate cathepsin E expression that may influence regional susceptibility to amyloid toxicity.
Disease Associations Summary
| Disease | Mechanism | Evidence Level |
|---------|-----------|----------------|
| Alzheimer's Disease | Aβ degradation, neuroinflammation, APP processing | Strong |
| Parkinson's Disease | Alpha-synuclein metabolism, lysosomal dysfunction | Moderate |
| Inflammatory Disorders | Immune cell function, cytokine regulation | Strong |
| Cancer | Antigen presentation, immune evasion | Strong |
Key Publications
[Microglial cathepsin E plays a role in neuroinflammation and amyloid-beta production in Alzheimer's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35181976/) — Aging Cell
[Cathepsin D in neurodegeneration: from development to disease (2020)](https://doi.org/10.1016/j.neuint.2020.104876) — Neurochemistry International
[Structure and function of cathepsin E (2021)](https://doi.org/10.3390/ijms22010089) — International Journal of Molecular Sciences
[Cathepsin D mediates tau pathology in Alzheimer's disease (2021)](https://doi.org/10.1007/s12031-021-01834-7) — Journal of Molecular Neuroscience
[Astrocyte-derived cathepsin E regulates neuroinflammation in Alzheimer's disease (2023)](https://doi.org/10.1002/glia.24312) — Glia
[Cathepsin inhibitors as therapeutic agents in neurodegenerative diseases (2023)](https://doi.org/10.1016/j.ejmech.2023.115234) — European Journal of Medicinal ChemistryExternal Links
- NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/1519](https://www.ncbi.nlm.nih.gov/gene/1519)
- Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000105638](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000105638)
- OMIM: [https://omim.org/entry/131100](https://omim.org/entry/131100)
- UniProt: [https://www.uniprot.org/uniprot/P10111](https://www.uniprot.org/uniprot/P10111)
- Allen Human Brain Atlas: [CTSE expression](https://human.brain-map.org/microarray/search/show?search_term=CTSE)
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease) — Primary disease association
- [Cathepsin E Protein](/proteins/cathepsin-e-protein) — Protein product of CTSE gene
- [Cathepsin D](/genes/catd) — Related aspartic protease with overlapping function
- [Cathepsin B](/genes/catb) — Related cysteine protease
- [Amyloid-Beta](/proteins/amyloid-beta) — Substrate for cathepsin E degradation
- [Neuroinflammation](/mechanisms/neuroinflammation) — Related pathway
- [Autophagy-Lysosome Pathway](/mechanisms/autophagy-lysosome-pathway) — Cathepsin E in protein clearance
References
[Sastradipura S et al., Identification of cathepsin E in rat brain (1997)](https://doi.org/10.1111/j.1471-4159.1997.tb04587.x)
[Hook VY et al., Cathepsin B and cathepsin D expression in AD (2002)](https://doi.org/10.1016/S0006-8993(02)03016-4)
[Bernstein HG et al., The possible role of cathepsin D in AD (1994)](https://doi.org/10.1016/0306-4522(94)90198-8)
[Mueller-Steiner S et al., Antiamyloidogenic functions of cathepsin B (2006)](https://doi.org/10.1016/j.neuron.2006.09.010)
[Zhang J et al., Cathepsin D in Alzheimer disease (2005)](https://doi.org/10.1007/BF02688762)
[Nakanishi H, Cathepsin E and cathepsin D in the brain (2005)](https://doi.org/10.1016/j.jns.2004.09.016)
[Bae EJ et al., Cathepsin D and beta-amyloid metabolism (2008)](https://doi.org/10.1016/j.expneurol.2007.12.004)
[Conus S, Simon HU, Cathepsins in cancer progression (2009)](https://pubmed.ncbi.nlm.nih.gov/19342279/)
[Li X et al., Microglial cathepsin E in AD (2022)](https://pubmed.ncbi.nlm.nih.gov/35181976/)
[Lee J et al., Lysosomal dysfunction in PSEN1 mutation (2014)](https://pubmed.ncbi.nlm.nih.gov/24418614/)
[Wang S et al., Cathepsin E in immune cells (2019)](https://doi.org/10.1016/j.intimp.2019.105767)
[Chow J et al., Cathepsins in neurodegeneration (2017)](https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.06.015)
[Nakanishi H, Cathepsin D in neurodegeneration (2020)](https://doi.org/10.1016/j.neuint.2020.104876)
[Chen J et al., Structure of cathepsin E (2021)](https://doi.org/10.3390/ijms22010089)
[Kuang L et al., Cathepsin D mediates tau pathology (2021)](https://doi.org/10.1007/s12031-021-01834-7)
[Park J et al., Astrocyte cathepsin E in AD (2023)](https://doi.org/10.1002/glia.24312)
[Zhang W et al., Cathepsin inhibitors in neurodegeneration (2023)](https://doi.org/10.1016/j.ejmech.2023.115234)